| Trial ID: | L0481 |
| Source ID: | NCT02275468
|
| Associated Drug: |
Fu-Zheng-Qu-Zhuo (Fzqz) Oral Liquid
|
| Title: |
Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Stage 3 Chronic Kidney Disease|Stage 4 Chronic Kidney Disease
|
| Interventions: |
DRUG: Fu-zheng-qu-zhuo (FZQZ) oral liquid
|
| Outcome Measures: |
Primary: composite end point, end stage renal disease (defined by the need for long-term dialysis or renal transplantation, or eGFR\<15ml/min) and all cause of death, 12 month after the treatmnet and 3 years of the follow up time | Secondary: the slope of the eGFR versus observation time, the decline of eGFR per-year, 12 month after the treatment
|
| Sponsor/Collaborators: |
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Collaborators: Fangshan Hospital of Traditional Chinese Medicine,|Peking University First Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
124
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-06
|
| Completion Date: |
2014-10
|
| Results First Posted: |
|
| Last Update Posted: |
2014-10-27
|
| Locations: |
Guang anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China|Fangshan Hospital of Traditional Chinese Medicine, Beijing, Beijing, China|Guang'an Men Hospital South, Beijing, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02275468
|
